Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cooper Pharmaceuticals is a well-established Greek pharmaceutical company founded in 1936, specializing in the development, manufacturing, and distribution of a broad range of pharmaceutical products. The company is particularly recognized for its expertise in sterile manufacturing, including ophthalmic solutions, ear drops, and injectable medicines produced in its EU-GMP certified facilities in Athens. Beyond its own branded generics, Cooper Pharmaceuticals operates as a significant Contract Manufacturing Organization (CMO) and CDMO, providing production services for international pharmaceutical firms. Their portfolio spans multiple therapeutic areas such as ophthalmology, cardiology, gastroenterology, and respiratory health. The company maintains a strong domestic presence in Greece while actively exporting products to various international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cooper Pharmaceuticals.